Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
2
×
detroit blog main
detroit top stories
drug development
financing
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accelerator
accent therapeutics
aducanumab
airbnb
alzheimer's disease
amazon web services (aws)
amblyotech
artificial intelligence (a.i.)
asklepios biopharmaceutical
athelas
atomwise
benchling
bioeurope
biogen
biomarin pharmaceutical
What
activity
admits
ago
approvals
big
bio
biogen
biotechs
clamped
classes
combinator
companies
covid
delays
developing
dug
economic
fast
fda
including
incubator
ipo
isn’t
life
lot
medicines
new
oric’s
previously
roundup
sciences
showing
sizable
spread
started
startup
tech
testing
they’re
welcome
Language
unset
Current search:
financing
×
cancer
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
